In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ACVC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Acute coronary syndrome in the people under 50 in a tertiary hospital

Session Poster Session 1

Speaker Alfredo Chauca Tapia

Event : Acute Cardiovascular Care 2016

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : ST-Elevation Myocardial Infarction (STEMI)
  • Session type : Poster Session

Authors : A Chauca Tapia (Cadiz,ES), U Martinez Capoccioni (Cadiz,ES), R Colman Llamozas (Cadiz,ES), M Herruzo Rojas (Cadiz,ES), R Del Pozo Contreras (Cadiz,ES), D Villanueva Ospino (Cadiz,ES), D Bartolome Mateos (Cadiz,ES)

Authors:
A Chauca Tapia1 , U Martinez Capoccioni1 , R Colman Llamozas1 , M Herruzo Rojas1 , R Del Pozo Contreras1 , D Villanueva Ospino1 , D Bartolome Mateos1 , 1University Hospital Puerta del Mar, Cardiology - Cadiz - Spain ,

Citation:
European Heart Journal Supplement ( 2010 ) 12 ( Supplement F ), F27

Background: The purpose of this research is to describe the acute coronary syndrome (ACS) in people under 50 years of age, and identify the most frequent risk factors in this group of patients.
Methods: Descriptive study of patients under 50 years of age admitted between January 2011 and December 2015 in a tertiary hospital with the diagnosis of ACS, to determine epidemiological characteristics, prevalence of cardiovascular risks factors, laboratory test and angiographic characteristics.
Results: During the study period, 61 patients under 50 years were admitted to our hospital with a diagnosis of ACS, the mean age 42.8±4.5 and 82% were men. 62.3% of admissions were due to STEMI. Single-vessel disease predominated (44.7%) and the coronary artery most frequently involved was the anterior descending artery (70.5%). The most prevalent risk factor in the study was smoking (86%) followed by overweight (44.2%), dyslipidemia (34%) and family history of coronary artery disease (31.1%). With respect to the laboratory test results, it must be highlighted the low mean value of HDL (39.8mg/dL) and albumin (3.9g/dL). 7 patients were readmitted (11.5%).
Conclusion: As we showed in our study, the prevalence of smoking, overweight and dyslipidemia are the main cardiovascular risk factors present in this group of patients and this results reinforce the need for primary preventive measures aimed at preventing young people from adopting unhealthy lifestyles.

Clinical/Angiographic characteristics Prevalence(%) Lab test Mean value
Hypertension 27.9 Hemoglobin 14.03 g/dl
DM 11.5 RDWSD 43.56 fL
Dyslipidemia 34 RDWCV 13.58 %
Family history of CAD 31.1 Platelets 258050 / µl
Tobacco 86.9 PDW 13.29 %
Alcohol 29.5 Creatinine 1 mg/dl
BMI≥25 44.2 Albumin 3.95 g/dL
1-vessel disease 65.6 Triglycerides 143.4 mg/dl
2-vessel disease 21.3 HDL 39.82 mg/dL
3-vessel disease 13.1 LDL 104.68 mg/dL
Anterior descending artery 70.5 HbA1c 5.59 %
Circumflex artery 31.1 hs troponin T (peak) 3163.58 ng/L
Right coronary artery 45.9 CK-MB (peak) 164 U/L
Readmission 11.5

The free consultation period for this content is over.

It is now only available year-round to ACVC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are